626 related articles for article (PubMed ID: 9950441)
1. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
Roth WK; Weber M; Seifried E
Lancet; 1999 Jan; 353(9150):359-63. PubMed ID: 9950441
[TBL] [Abstract][Full Text] [Related]
2. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.
Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L
Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568
[TBL] [Abstract][Full Text] [Related]
3. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
4. [Molecular biological screening of viruses important to transfusion medicine].
Wolff C; Hörnschemeyer D; Skurtopulos M; Petersen N; Beyer J; Seidel K; Mutz A; Kleesiek K
Beitr Infusionsther Transfusionsmed; 1994; 32():102-9. PubMed ID: 9480064
[TBL] [Abstract][Full Text] [Related]
5. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
[TBL] [Abstract][Full Text] [Related]
6. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
7. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
Nübling CM; Chudy M; Volkers P; Löwer J
Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
[TBL] [Abstract][Full Text] [Related]
8. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
Japanese Red Cross NAT Screening Research Group
Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
[TBL] [Abstract][Full Text] [Related]
9. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
[TBL] [Abstract][Full Text] [Related]
10. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
11. PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service.
Schottstedt V; Tuma W; Bünger G; Lefèvre H
Biologicals; 1998 Jun; 26(2):101-4. PubMed ID: 9811513
[TBL] [Abstract][Full Text] [Related]
12. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
[TBL] [Abstract][Full Text] [Related]
13. [Routine PCR screening for HBV, HCV and HIV-I genome in a large blood donation services--experiences and initial results].
Schottstedt V; Tuma W; Bünger G; Lakenberg P
Beitr Infusionsther Transfusionsmed; 1997; 34():21-5. PubMed ID: 9417342
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ
Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
[TBL] [Abstract][Full Text] [Related]
15. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.
Meng Q; Wong C; Rangachari A; Tamatsukuri S; Sasaki M; Fiss E; Cheng L; Ramankutty T; Clarke D; Yawata H; Sakakura Y; Hirose T; Impraim C
J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017
[TBL] [Abstract][Full Text] [Related]
16. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study.
Jarvis L; Becker J; Tender A; Cleland A; Queiros L; Aquiar A; Azevedo J; Aprili G; Bressan F; Torres P; Nieto S; Ursitti A; Montoro J; Vila E; Ramada C; Saldanha J
Transfusion; 2008 Sep; 48(9):1853-61. PubMed ID: 18513254
[TBL] [Abstract][Full Text] [Related]
18. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
19. Predonation screening of candidate donors and prevention of window period donations.
Lieshout-Krikke RW; Zaaijer HL; van de Laar TJ
Transfusion; 2015 Feb; 55(2):373-8. PubMed ID: 25130605
[TBL] [Abstract][Full Text] [Related]
20. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.
Moiz B; Moatter T; Shaikh U; Adil S; Ali N; Mahar F; Shamsuddin N; Khurshid M
Transfusion; 2014 Jun; 54(6):1652-9. PubMed ID: 24383918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
